Company intelligence / Profile preview

Enzyme

San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Enzyme is a life sciences-focused software company that provides a cloud-based Quality Management System (QMS) and compliance platform. The company's software is designed to help biotech, pharmaceutical, and medical device companies manage regulatory requirements, product development, and quality assurance. By automating workflows for document control, training, and CAPA (Corrective and Preventive Actions), Enzyme accelerates the path to market for regulated products. Their platform integrates with common development tools to streamline the submission process for FDA and other global regulatory bodies.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Enzyme.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enzyme.

Explore the full profile